We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-3.47%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$119B
AUM Growth
-$5.47B
Cap. Flow
+$963M
Cap. Flow %
0.81%
Top 10 Hldgs %
23.93%
Holding
4,385
New
262
Increased
2,061
Reduced
1,644
Closed
273

Sector Composition

Rank Sector Weight
1 Technology 14.55%
2 Financials 8.81%
3 Healthcare 8.45%
4 Industrials 6.22%
5 Consumer Discretionary 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACNT icon
3476
Ascent Industries
ACNT
$134M
$270K ﹤0.01%
+16,799
New +$288K
NETL icon
3477
Colterpoint Net Lease Real Estate ETF
NETL
$54.1M
$270K ﹤0.01%
9,191
+1,977
+27% +$57.4K
PDO
3478
PIMCO Dynamic Income Opportunities Fund
PDO
$1.84B
$270K ﹤0.01%
+15,909
New +$284K
MAT icon
3479
Mattel
MAT
$4.25B
$269K ﹤0.01%
12,092
+604
+5% +$13.8K
ONL
3480
Orion Office REIT
ONL
$161M
$269K ﹤0.01%
19,232
-13,409
-41% -$226K
NMR icon
3481
Nomura Holdings
NMR
$29.2B
$268K ﹤0.01%
63,437
+2,726
+4% +$12.3K
OCUL icon
3482
Ocular Therapeutix
OCUL
$2.22B
$268K ﹤0.01%
54,099
+246
+0.5% +$1.36K
GDRX icon
3483
GoodRx Holdings
GDRX
$1.27B
$267K ﹤0.01%
13,806
+2,675
+24% +$61.3K
KFRC icon
3484
Kforce
KFRC
$1.08B
$267K ﹤0.01%
3,610
-2,627
-42% -$187K
WPRT
3485
Westport Fuel Systems
WPRT
$32.7M
$267K ﹤0.01%
16,871
-40
-0.2% -$715
MIRM icon
3486
Mirum Pharmaceuticals
MIRM
$6.02B
$266K ﹤0.01%
12,098
-6,555
-35% -$134K
ORLA
3487
DELISTED
Orla Mining
ORLA
$266K ﹤0.01%
55,457
+750
+1% +$3.01K
RAMP icon
3488
LiveRamp
RAMP
$2.31B
$265K ﹤0.01%
7,097
-1,884
-21% -$78.7K
RNGR icon
3489
Ranger Energy Services
RNGR
$405M
$265K ﹤0.01%
25,847
+12,343
+91% +$128K
NKLA
3490
DELISTED
Nikola Corporation Common Stock
NKLA
$265K ﹤0.01%
826
-151
-15% -$38.5K
TELL
3491
DELISTED
Tellurian Inc.
TELL
$265K ﹤0.01%
49,968
-68,746
-58% -$232K
FTLS icon
3492
First Trust Long/Short Equity ETF
FTLS
$2.5B
$263K ﹤0.01%
+5,194
New +$261K
RFFC icon
3493
ALPS Active Equity Opportunity ETF
RFFC
$31M
$263K ﹤0.01%
5,622
-42
-0.7% -$1.93K
SSO icon
3494
ProShares Ultra S&P500
SSO
$8.51B
$262K ﹤0.01%
8,000
TTM
3495
DELISTED
Tata Motors Limited
TTM
$262K ﹤0.01%
+9,377
New +$289K
HMN icon
3496
Horace Mann Educators
HMN
$2.1B
$261K ﹤0.01%
6,238
-1,660
-21% -$66.6K
CORZ
3497
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$261K ﹤0.01%
31,678
+5,350
+20% +$47.3K
ILPT
3498
Industrial Logistics Properties Trust
ILPT
$611M
$260K ﹤0.01%
11,483
+564
+5% +$12.9K
DYFN
3499
DELISTED
Angel Oak Dynamic Financial Strategies Income Term Trust
DYFN
$260K ﹤0.01%
+14,049
New +$270K
JRS icon
3500
Nuveen Real Estate Income Fund
JRS
$248M
$259K ﹤0.01%
21,910
+2,000
+10% +$23.2K

Similar funds

Raymond James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Raymond James & Associates held 4,385 positions worth $119B, down 4.4% from $124B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2022 filing shows 262 new, 2,061 increased, 1,644 reduced and 273 closed positions. Its largest new stake was Shell: 688,334 shares worth $37.8M. The largest sale was iShares Ultra Short Duration Bond Active ETF, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2022 buy was Shell: 688,334 shares worth $37.8M.
  • Raymond James & Associates added most to Broadcom in Q1 2022, an estimated $236M increase.
  • Raymond James & Associates's biggest Q1 2022 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $172M.
  • Raymond James & Associates fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $154M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $119B portfolio in Q1 2022.
  • Raymond James & Associates opened 262 new positions and closed 273 in Q1 2022.
  • Raymond James & Associates's portfolio value fell 4.4% quarter-over-quarter to $119B.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.